title: Activity of cetuximab as single agent in a patient with relapsed multiple myeloma.
authors.forename: Boris
authors.initials: B
authors.lastname: Böll
authors.forename: Dennis A
authors.initials: DA
authors.lastname: Eichenauer
authors.forename: Bastian
authors.initials: B
authors.lastname: Von Tresckow
authors.forename: Denissa
authors.initials: D
authors.lastname: Peine
authors.forename: Michael
authors.initials: M
authors.lastname: Hallek
authors.forename: Andreas
authors.initials: A
authors.lastname: Engert
authors.forename: Kai
authors.initials: K
authors.lastname: Hübel
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000068818:Cetuximab; D066246:ErbB Receptors / Q000378:metabolism; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D008024:Ligands; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D012008:Recurrence; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D007074:Immunoglobulin G; D008024:Ligands; D066246:ErbB Receptors; D000068818:Cetuximab